Trial Profile
A randomized, double-blind, placebo-controlled, interleaved, ascending dose study, to evaluate safety, tolerability and pharmacokinetics of single oral doses of AQW051; to evaluate the effect of food on the pharmacokinetics of AQW051, in Japanese healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2013
Price :
$35
*
At a glance
- Drugs VQW 765 (Primary)
- Indications Psychotic disorders
- Focus Adverse reactions; Pharmacokinetics
- 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
- 21 Jun 2007 Status change from in progress to completed
- 30 Dec 2006 Status change